PDC and neoplasm: Possibly, PHD inhibition during carcinogenesis can readily prime future tumour cells to react differently to later hypoxic stimuli, and give rise to more aggressive mixed phenotype cancers, with increased LPC characteristics and an increased risk for therapy resistance and metastasis (Bogaerts et al., 2014[2]).